Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Below, you will find a list of sessions focused on anti-obesity medications, specifically GLP-1 agonists that we are eagerly looking forward to at #ObesityMedicine2025
GLP-1 therapy is a breakthrough in healthy weight maintenance but can sometimes bring about challenges such as muscle loss, digestive discomfort, and nutrient deficiencies
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
This supports that the short-term anti-diabetic effect of GLP-1 is mainly due to slowing of gastric emptying and consequently a reduced rate of carbohydrate absorption
These medicines have also yielded meaningful benefits for obese individuals who were unable to achieve adequate weight reduction through lifestyle modifications
He is the founder of the Boston Healthcare Cloud & AI Community and speaks globally on responsible AI adoption in healthcare.
US$ 20.53
US$ 25.81
US$ 20.68
US$ 25.69
US$ 24.85
US$ 29.89
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 26.41
